title: Immune hemolytic anemia after treatment with pemetrexed for lung cancer.
authors.forename: Gun Min
authors.initials: GM
authors.lastname: Park
authors.forename: Kyou Sup
authors.initials: KS
authors.lastname: Han
authors.forename: Yoon Hwan
authors.initials: YH
authors.lastname: Chang
authors.forename: Cheol Hyeon
authors.initials: CH
authors.lastname: Kim
authors.forename: Jae Cheol
authors.initials: JC
authors.lastname: Lee
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced*; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D005971:Glutamates / Q000009:adverse effects*; D006147:Guanine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000068437:Pemetrexed
chemical_list: D000964:Antimetabolites, Antineoplastic; D005971:Glutamates; D000068437:Pemetrexed; D006147:Guanine